Chen‐Yen Yang

714 total citations
10 papers, 542 citations indexed

About

Chen‐Yen Yang is a scholar working on Pathology and Forensic Medicine, Dermatology and Molecular Biology. According to data from OpenAlex, Chen‐Yen Yang has authored 10 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Dermatology and 3 papers in Molecular Biology. Recurrent topics in Chen‐Yen Yang's work include Cutaneous lymphoproliferative disorders research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Liver Diseases and Immunity (3 papers). Chen‐Yen Yang is often cited by papers focused on Cutaneous lymphoproliferative disorders research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Liver Diseases and Immunity (3 papers). Chen‐Yen Yang collaborates with scholars based in United States, Australia and Estonia. Chen‐Yen Yang's co-authors include Patrick S.C. Leung, M. Eric Gershwin, Iannis E. Adamopoulos, Christopher L. Bowlus, Aftab A. Ansari, Xiong Ma, Linda Wu, Guoxiang Yang, Naga Chalasani and Ross L. Coppel and has published in prestigious journals such as Blood, Hepatology and Cancer Research.

In The Last Decade

Chen‐Yen Yang

10 papers receiving 533 citations

Peers

Chen‐Yen Yang

HEPAT

PFM

EPIDE

SURGE

IMMUN

Ahmet Kemal Gürbüz Türkiye

Venkateswarlu Kondragunta United States

Mohannad Abou Saleh United States

B. Cherruau France

Chiara Giannitti Italy

Sandeep Dhaliwal Canada

Yoshiaki Maeda Japan

A Lucariello Italy

Omar Racchi Italy

Kunio Morozumi Japan

Ahmet Kemal Gürbüz Türkiye

Chen‐Yen Yang

72 ×0.3

HEPAT

184 ×1.0

PFM

84 ×0.4

EPIDE

235 ×1.7

SURGE

43 ×0.4

IMMUN

Citations per year, relative to Chen‐Yen Yang Chen‐Yen Yang (= 1×) peers Ahmet Kemal Gürbüz

Countries citing papers authored by Chen‐Yen Yang

Since Specialization

Citations

This map shows the geographic impact of Chen‐Yen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Yen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Yen Yang more than expected).

Fields of papers citing papers by Chen‐Yen Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen‐Yen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Yen Yang. The network helps show where Chen‐Yen Yang may publish in the future.

Co-authorship network of co-authors of Chen‐Yen Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Yen Yang. A scholar is included among the top collaborators of Chen‐Yen Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Yen Yang. Chen‐Yen Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Wang, Linlin, Chen‐Yen Yang, Kwun Wah Wen, et al.. (2021). Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models. Blood Advances. 6(7). 2290–2302. 15 indexed citations

Vu, John P., Chen‐Yen Yang, Mint Sirisawad, et al.. (2021). Glutamate-cysteine ligase catalytic subunit as a therapeutic target in acute myeloid leukemia and solid tumors.. American Journal of Cancer Research. 11(6). 2911–2927. 7 indexed citations

Yang, Chen‐Yen, Linlin Wang, Shervin Afghani, et al.. (2020). Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC. Journal of Investigative Dermatology. 141(2). 364–373. 19 indexed citations

Vu, Khoan, Chen‐Yen Yang, Laura B. Pincus, et al.. (2019). Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study. Clinical Cancer Research. 26(5). 1000–1008. 33 indexed citations

Yang, Chen‐Yen, et al.. (2017). Abstract 4589: Preclinical investigation of SGN-CD70A antibody-drug conjugate in T cell lymphomas. Cancer Research. 77(13_Supplement). 4589–4589. 4 indexed citations

Ai, Weiyun Z., Chen‐Yen Yang, Shervin Afghani, et al.. (2015). Pathway-Directed High Throughput Drug Screen Identifies PI3K Inhibitors That Synergistically Potentiate Anti-Tumor Activity of HDAC Inhibitors in Mycosis Fungoides and Sezary Syndrome. Blood. 126(23). 2755–2755. 2 indexed citations

Norman, Gary L., Chen‐Yen Yang, Heather P. Ostendorff, et al.. (2014). Anti‐kelch‐like 12 and anti‐hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver International. 35(2). 642–651. 62 indexed citations

Yang, Chen‐Yen, Patrick S.C. Leung, Iannis E. Adamopoulos, & M. Eric Gershwin. (2013). The Implication of Vitamin D and Autoimmunity: a Comprehensive Review. Clinical Reviews in Allergy & Immunology. 45(2). 217–226. 217 indexed citations

Yang, Chen‐Yen, Xiong Ma, Koichi Tsuneyama, et al.. (2013). IL-12/Th1 and IL-23/Th17 Biliary Microenvironment in Primary Biliary Cirrhosis: Implications for Therapy. Hepatology. 59(5). 1944–1953. 170 indexed citations

10.

Uibo, Raivo, Kai Kisand, Chen‐Yen Yang, & M. Eric Gershwin. (2012). Primary biliary cirrhosis: a multi‐faced interactive disease involving genetics, environment and the immune response. Apmis. 120(11). 857–871. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact